Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Structure and function of P-glycoprotein]

J Robert1

  • 1Fondation Bergonié et université de Bordeaux II, France.

Bulletin Du Cancer
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

P-glycoprotein (P-gp) is a key transporter in multidrug resistance, crucial for drug detoxification and anticancer therapy. Understanding its hypothetical 3D structure and lateral drug extrusion mechanism is vital for advancing cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative cardiotoxicity of idarubicin and doxorubicin using the isolated perfused rat heart model.

Anti-cancer drugs·1999
Same author

Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin.

British journal of cancer·1999
Same author

A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·1999
Same author

Thoracic outlet syndrome: influence of personal history and surgical technique on long-term results.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·1999
Same author

Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

American journal of respiratory and critical care medicine·1999
Same author

Beneficial effects of leukocyte-depleted blood and low-potassium dextran solutions on microvascular permeability in preserved porcine lung.

American journal of respiratory and critical care medicine·1999
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
Same journal

[Robotics in oncological surgery].

Bulletin du cancer·2026
See all related articles

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • P-glycoprotein (P-gp) is a membrane-bound ATPase transporter.
  • P-gp plays a significant role in multidrug resistance (MDR).
  • Its involvement in drug detoxification and anticancer drug transport is well-established.

Purpose of the Study:

  • To elucidate the hypothetical three-dimensional structure of P-glycoprotein.
  • To understand the molecular mechanism of action of P-gp.
  • To explore P-gp's role in drug extrusion and its regulation.

Main Methods:

  • cDNA sequencing for primary structure determination.
  • Hypothetical modeling for three-dimensional structure.
  • Analysis of drug and modulator binding sites.

Related Experiment Videos

  • Investigation of phosphorylation-mediated regulation.

    • Main Results:

    • The primary structure of P-gp is known, but its 3D structure remains hypothetical.
    • Evidence suggests P-gp extrudes drugs laterally within the membrane.
    • Multiple drug and modulator binding sites are likely present.
    • P-gp activity appears to be regulated by phosphorylation.

    Conclusions:

    • Further research involving purification and reconstitution of P-gp is necessary.
    • Understanding P-gp's mechanism of action will improve anticancer drug efficacy.
    • Elucidating P-gp structure and function is critical for overcoming multidrug resistance.